Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2026)
Xenon Pharmaceuticals (XENE) reported Treasury Shares of $671147.0 for Q1 2026, up 121.2% year-over-year from $303417.0 in Q1 2025, and up 92.31% quarter-over-quarter from $348994.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 3 years of Treasury Shares data on file, last reported at $671147.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $671147.0, up 121.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $671147.0 (up 121.2% YoY), and the FY2025 annual result was $348994.0, up 66.19% from the prior year.
- Treasury Shares grew to $671147.0 in Q1 2026 per XENE's latest filing, from $348994.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $671147.0 in Q1 2026 and troughed at $192000.0 in Q1 2024.
- A 3-year average of $295950.9 and a median of $257450.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2025 and 2026: Treasury Shares rose 22.6% in 2025, then soared 121.2% in 2026.
- A 3-year view of Treasury Shares shows it stood at $210000.0 in 2024, then surged by 66.19% to $348994.0 in 2025, then jumped by 92.31% to $671147.0 in 2026.
- Business Quant data shows XENE's Treasury Shares at $671147.0 in Q1 2026, $348994.0 in Q4 2025, and $257450.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | 671,147.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 671,147.00 |
| Mar 31, 2026 | 671,147.00 |
| Dec 31, 2025 | 348,994.00 |
| Dec 31, 2025 | 348,994.00 |
| Sep 30, 2025 | 257,450.00 |
| Sep 30, 2025 | 257,450.00 |
| Jun 30, 2025 | 275,550.00 |
| Jun 30, 2025 | 275,550.00 |
| Mar 31, 2025 | 303,417.00 |
| Mar 31, 2025 | 303,417.00 |
| Dec 31, 2024 | 210,000.00 |
| Dec 31, 2024 | 210,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |